Biomodels

Pre-Clinical CRO for Mucosal Injury (Mucositis), Cancer and Inflammation Studies

Avaxia Biologics to Collaborate with Biomodels on Antibody Therapeutic for Inflammatory Bowel Disease

Avaxia Biologics, a biotechnology company developing oral antibodies for diseases of the GI tract, has announced that it has been awarded a Phase I Small Business Innovation Research grant...

Avaxia Biologics to Collaborate with Biomodels on Antibody Therapeutic for Inflammatory Bowel Disease

Biomodels' Oral Mucositis Expertise Speeds Up FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients

Pre-clinical research organisation Biomodels has announced that it has successfully collaborated with ActoGeniX, a development stage biopharmaceutical company, in obtaining FDA approval for...

Biomodels' Oral Mucositis Expertise Speeds Up FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients

Biomodels Scientists Develop Novel Model for Cancer Treatment-Related Fatigue

Scientists at Biomodels have successfully developed the first model that accurately duplicates human cancer treatment-related fatigue (CTRF). The new model shows that, as in human cancer...

Biomodels Scientists Develop Novel Model for Cancer Treatment-Related Fatigue

Lubris and Biomodels Report Potential New Therapy for Osteoarthritis

Medical researchers have reported findings demonstrating that injecting the protein lubricin into knee joints can dramatically reduce cartilage degeneration. The discovery by scientists...

Lubris and Biomodels Report Potential New Therapy for Osteoarthritis